MR. BHARGAV KOTADIA
Managing Director at Sahajanand Group

Is a Purdue University alumni and second generation entrepreneur who is spearheading India’s rise as a manufacturer of world class healthcare equipment. His success story is as much a triumph of innovation and leadership as it is reminder of what the human spirit can achieve as long as it is focussed and fearless.  
 

For most of us, David taking on Goliath (and winning against all odds) is a story from an ancient legend. For Bhargav Kotadia, it’s simply a blueprint for business strategy. Something his company SMT (Sahajanand Medical Technologies) –  a Rs 500 crore Mumbai based stent manufacturing leader and disruptor – is becoming increasingly good at. 


THE BIRTH OF A LEGACY 


It’s perhaps best to start at the beginning when in 1997, Bhargav’s father Dhirajlal Kotadia laid the foundation of a what can be described as a modern fairy tale. Hailing from a humble background in Saurashtra’s Junagadh district, Dhirajlal – with an electrical engineering background – decided to start his own business. SMT – today a stent making phenomenon – almost had a Google-like genesis, starting off from a small room with four assistants. An ingenious mind and hard-working soul, Dhirajlal’s winning formula of iteratively engineering and re-engineering upon fresh ideas went on to breathe life into India’s first manufacturer of affordable cardiovascular medical stents. His instruments didn’t just match global standards, but – thanks to their innovative edge - gave industry Goliaths such as Abbott, Boston Scientific, and Medtronic sit up and take notice.  SMT’s cardiac stents were being admired by the medical fraternity globally. When one takes into account that Dhirajlal scaled this mountain in the pre-Google age with a home grown team and limited access to resources and networks, the magnitude of his achievement appears a lot bigger. 
After Dhirajlal took a backseat due to health reasons, however, the company hit a trough in its spectacular journey. A lack of patents meant that competitors could easily replicate  SMT’s proprietary ideas and approaches. The global Goliaths had stepped up their own R&D and were making rapid advances. SMT’s painstakingly built goodwill and reputation was in danger of erosion. Market share had dipped alarmingly. Dhirajlal’s labour-of-love was starting at an uncertain future. 


TAKING ON A CHALLENGE 


Into this crossroads of confusion stepped the scion and torchbearer of the family legacy,  Bhargav Kotadia. Bhargav had initially been focussing on the Group’s other  frontiers – namely the diamond-cutting machine and dietary supplements divisions, which were also making a dent in their respective spaces. It was only in 2013 that he turned his attention to the ailing SMT. Soft spoken and introverted, Bhargav was gifted with a steely determination - and was committed to turn things around for SMT. 
A sharp and analytical mind, it didn’t take long for Bhargav to realize where the ‘blockages’ (pun intended) lay. R&D, market presence and backward integration all begged renewed and dedicated attention. Rebooting the ‘winner’s momentum’ in a team that was now beginning to have self-doubts, quite apart from upgrading technologies, systems and processes, wasn’t easy. But then again, great milestones never start out easy. However, a focus on in-house innovation, training and bolstering the sales force got things moving. In time, SMT started to  regain lost ground and market share. 


ENGINEERING RESURRECTION 


As attention and accolades starting pouring in again from all quarters - the sense of deja-vu was palpable. A study involving patients from multiple European countries established that the quality of SMT’s devices were right up there with the ‘best’ - in parameters like performance and safety. This wasn’t just a moment of celebration – it was also a validation of the team’s commitment and Bhargav’s unrelenting resolution. Impressed with the new found climate of positivity and SMT’s culture of innovation (that visibly ran right across the rank & fibre of the organization), funders started spotting a bright future for the organization and began to invest in this ‘resurrection’. 
Bhargav’s mission had come full circle. He had achieved the holy grail of successfully blending quality with affordability. SMT was a sparkling feather in the new ‘Make In India’ narrative. SMT single-handedly injected fresh conviction into India’s quest of becoming a global hub in affordable healthcare. Perhaps most satisfyingly, the healing touch of technology was now accessible for the ‘next billion’.  


DECODING THE DISRUPTION 


So how did Bhargav turn the story around so tellingly? It all boils down to a mix of upbringing and passion. Being born to a pioneer, Bhargav had closely witnessed – and been inspired by – Dhirajlal’s rare success of putting a home-grown entrepreneurial story on the world map. His father’s advice – Whatever you do, leave it in a better state than when you found it – still acts as gospel. Faith in human ability and his team remains a vital ingredient to success. A classic brew that blends global perspectives (a result of a foreign education) with quintessentially ‘Indian values’ lies behind Bhargav’s open and flexible approach – one that always respects both sides of a story and brings balance to his boardroom strategies. An ability to learn from the lessons of adversity amps up the resilience factor while endowing his initiatives with the power of insight. When you add an economics background, a brain that loves to solve problems and a driving ambition of making a difference to the maximum number of souls in the minimum possible time, it translates to a potent recipe for disruption. His many awards act as a reminder of the disruptive transformation he has undeniably ushered in healthcare. 


THE FUTURE IS CALLING 


Challenge is everywhere, but like all true-blue visionaries, Bhargav is quick to spot the upsides and opportunities first. The market for cardiovascular stents is growing. And if SMT has to own a bigger pie, everything will need to be scaled up – from research to production to marketing. The good news is that this isn’t a problem, because optimism tends to be infectious. Led from the front by Bhargav’s buoyant stewardship, the company is actively eyeing expanding its product portfolio. Yes, it’s an exciting time to be part of Bhargav’s team today. 


THE STORY IS JUST BEGINNING 


Ask the humble Bhargav Kotadia, though, and he’ll be equanimous about it. It’s all a part of his plan. A grander design. A burning ambition – of elevating Sahajanand Medical Technologies into a global super-power in Medical Devices. And India into a global hub of healthcare. Those who know him well realize that the man is getting there. Steadily. Surely. One headline, and one milestone, at a time. 

Subscribe Our Newsletter

MR. SANJAY JHA
By: - 2020-08-08 22:42:23

NEWS

By: Staff Writer-21 Aug, 2020

By: Bloomberg-21 Sept, 2020

By: PTI-21 Sept, 2020

By: AFP-21 Sept, 2020

By: PTI-21 Sept, 2020

#

By: Bloomberg-18 Sept, 2020

#

By: Leroy Leo-18 Sept, 2020

#

By: Anulekha Ray-19 Sept, 2020

#

By: REUTERS-20 Sept, 2020

By: Reuters-18 Sept, 2020

By: Serena Gordon-18 Sept, 2020

By: Dennis Thompson-18 Sept, 2020

By: Alan Mozes-18 Sept, 2020

By: AFP-18 Sept, 2020

By: Bloomberg-18 Sept, 2020

By: PTI-17 Sept, 2020

By: PTI-17 Sept, 2020

By: Serena McNiff-17 Sept, 2020

By: PTI-17 Sept 2020

By: Heidi Ledford-16 Sept, 2020

By: Alison Abbott-16 Sept, 2020

By: Michael Marshall-16 Sept, 2020

By: Carolyn Crist-16 Sept, 2020

By: Clare Watson-16 Sept, 2020

By: Michelle Cortez , Bloomberg-15 Sept, 2020

By: Anonymous-15 Sept, 2020

By: David Cyranoski & Smriti Mallapaty-15 Sept, 2020

By: Reuters-15 Sept, 2020

By: Reuters-15 Sept, 2020

By: Noah Higgins-Dunn & Christina Farr-15 Sept, 2020

By: Kevin Stankiewicz-15 Sept, 2020

By: Sam Shaed-15 Sept, 2020

By: PTI-14 Sept, 2020

By: Anonymous-13 Sept, 2020

By: Anonymous-13 Sept, 2020

By: Anonymous-13 Sept, 2020

By: Anonymous-13 Sept, 2020

By: Anonymous-12 Sept 2020

By: Anonymous-12 Sept 2020

By: Ralph Ellis-12 Sept 2020

By: Anonymous-12 Sept 2020

By: Newsroom-12 Sept 2020

By: Newsroom-12 Sept 2020

#

By: Mint News-10 Sep 2020

#

By: Kathleen Doheny-08 Sept 2020

#

By: Linda A. Johnson-08 Sept 2020

#

By: Nature-09 Sept 2020

#

By: Lauran Neergaard-09,Sept, 2020

#

By: Surajit Dasgupta-08, Sept, 2020

#

By: HealthDay Reporter-04 Sept2 020

By: PTI-08 Sept, 2020

By: Jon Emont , The Wall Street Journal-08 Sept, 2020

By: John McCormick-08 Sept, 2020

By: The Associated Press-08 Sept, 2020

By: PTI-08 Sept, 2020

By: AP News-08 Sept, 2020

By: Joslin Diabetes Center-05 Sept, 2020

By: Suzi Ring , Bloomberg-05 Sept, 2020

By: Peter Loftus-05 Sept, 2020

By: Robert Preidt-05 Sept, 2020

By: Serena Gordon-05 Sept, 2020

By: Kerry Dooley Young-05 Sept, 2020

By: Anonymous-05 Sept, 2020

By: Anonymous-04 Sept, 2020

By: Heidi Ledford-04 Sept, 2020

By: WEBMD NEWS BRIEF-04 Sept, 2020

#

By: Brenda Goodman, MA-04 Sept, 2020

#

By: Newsroom-04 Sept, 2020

#

By: PTI-3 Sept, 2020

By: Kate Kelland , Reuters-3 Sept, 2020

#

By: Gayathri Vaidyanathan-03 Sept, 2020

#

By: Carolyn Crist-2 Sept, 2020

#

By: Neetu Chandra Sharma-2 Sept, 2020

#

By: Newsroom-2 Sept, 2020

#

By: Anonymous-2 Sept, 2020

#

By: Newsroom-2 Sept, 2020

#

By: BRUCE GOLDMAN-2 Sept, 2020

#

By: Newsroom-2 Sept, 2020

#

By: Newsroom-2 Sept, 2020

#

By: Reuters-1 Sep, 2020

#

By: Reuters-1 Sep, 2020

#

By: Reuters-1 Sep, 2020

#

By: Reuters-1 Sep, 2020

#

By: Reuters-1 Sep, 2020

#

By: Jeff Tollefson-1 Sep, 2020

#

By: Reuters-1 Sep, 2020

#

By: Heidi Ledford-1 Sep, 2020

#

By: Reuters-30 Aug, 2020

#

By: Reuters-30 Aug, 2020

#

By: Reuters-18 Aug, 2020

#

By: Ricardo Alonso-Zaldivar-30 Aug, 2020

#

By: Reuters-30 Aug, 2020

#

By: Reuters-30 Aug, 2020

#

By: Reuters-29 Aug, 2020

#

By: Reuters-29 Aug, 2020

#

By: Smriti Mallapaty-29 Aug, 2020

#

By: Newsroom-29 Aug, 2020

#

By: Reuters-29 Aug, 2020

#

By: Reuters-29 Aug, 2020

#

By: Reuters-29 Aug, 2020

#

By: Sachin Ravikumar, Derek Francis, Nivedita Bhattacharjee-26 Aug, 2020

#

By: Reuters-26 Aug, 2020

#

By: Giorgia Guglielmi-21 Aug, 2020

#

By: Reuters-25 Aug, 2020

#

By: Anulekha Ray-24 Aug, 2020

#

By: All India | ANI-26 Aug, 2020

#

By: Andrew Meldrum, Mogomotsi Magome and Lauran Neergaard-26 Aug, 2020

#

By: LONDON (Reuters)-26 Aug, 2020

#

By: Dr. Eric Nudleman-25 Aug, 2020

#

By: PTI-25 Aug, 2020

#

By: LiveMint-25 Aug, 2020

#

By: Junko Fujita-25 Aug, 2020

#

By: Reuters-25 Aug, 2020

#

By: Nandita Bose, Aram Roston-25 Aug, 2020

#

By: FP Staff-25 Aug, 2020

Study Adds to Evidence That Odor-Sensing

By: Newsroom-24 Aug, 2020

Covid-19 vaccine update: Pfizer, BioNTec

By: FE Online-24 Aug, 2020

Covid-19 vaccine update: Cuba, N Korea,

By: FE Online-24 Aug, 2020

COVID-19 recovery rate reaches 74.69 per

By: PTI-24 Aug, 2020

COVID-19 caseload in India crosses 30-la

By: PTI-24 Aug, 2020

Factbox: Latest on the worldwide spread

By: Reuters-24 Aug, 2020

India crosses crucial milestone of testi

By: PTI-23 Aug, 2020

COVID-19 diagnostic test: Saliva-based t

By: FE Online-23 Aug, 2020

COVID-19: India adds nearly 70,000 cases

By: FE Online-23 Aug, 2020

Novartis immuno-oncology drug candidate

By: Reuters-23 Aug, 2020

#

By: PTI-23 Aug, 2020

#

By: Reuters-23 Aug, 2020

Coronavirus Updates: Maharashtra reports

By: FP Staff-21 Aug, 2020

Russia's 'Sputnik V' COVID-19 vaccine to

By: Reuters-21 Aug, 2020

Asia Today: India has record high of 69,

By: AP-21 Aug, 2020

Endless first wave: how Indonesia failed

By: Reuters-21 Aug, 2020

Diagnostics firms eye consolidation

By: livemint-21 Aug, 2020

Accuracy Problems with Widely Used Coron

By: Associated Press-21 Aug, 2020

Coronavirus is Not Ready to Budge, So Wh

By: N C Satpathy-20 Aug, 2020

What Is Digital Health ID? Here’s What Y

By: Jagmeet Singh-20 Aug, 2020

How Much Vitamin C Is Too Much Vitamin C

By: Rupali Dutta-20 Aug, 2020

One in four Indians could have been infe

By: Savio Shetty-20 Aug, 2020

Roche, Regeneron link up on COVID-19 ant

By: Reuters-19 Aug, 2020

Explainer: World Health Organization's s

By: Reuters-19 Aug, 2020

Australia hails vaccine deal as virus su

By: Reuters-19 Aug, 2020

COVID-19: Govt to review guidelines to s

By: FE Online-19 Aug, 2020

Coronavirus vaccine update: India begins

By: FE Online-19 Aug, 2020

Immune response after mild COVID-19 is p

By: Reuters-19 Aug, 2020

Recovered cases 2.93 times the number of

By: livemint-19 Aug, 2020

Study links COVID-19 to rise in childhoo

By: Reuters-19 Aug, 2020

WHO blasts 'vaccine nationalism' in last

By: Reuters-19 Aug, 2020

Novavax begins mid-stage study of COVID-

By: Reuters-18 Aug, 2020

COVID-19 vaccine: Do vaccines need to be

By: FE Online-18 Aug, 2020

Russia to roll out vaccine by end of Aug

By: Financial Express-18 Aug, 2020

Testing of CanSino's COVID-19 candidate

By: Reuters-18 Aug, 2020

COVID-19 warriors will be first to get v

By: PTI-18 Aug, 2020

Covid-19, Cold, Flu or Allergy: Know the

By: HT?Correspondent Hindustan Times-17 Aug, 2020

Eat Right, Smile Bright - Acidic Food an

By: FP Studio-17 Aug, 2020

Coronavirus Updates: Karnataka reports 7

By: FP Staff-17 Aug, 2020

Health ID pilot programme to start with

By: FE Online-17 Aug, 2020

Mexico needs 200 million COVID-19 vaccin

By: Reuters-17 Aug, 2020

Factbox: Latest on worldwide coronavirus

By: Reuters-17 Aug, 2020

The Latest: S. Korea reports largest vir

By: The Associated Press-16 Aug, 2020

PM Modi announces launch of National Dig

By: By EH News Bureau-16 Aug, 2020

Russian doctors wary of rapidly approved

By: Reuters-16 Aug, 2020

Need to wage war against NCDs, not just

By: By EH News Bureau-16 Aug, 2020

COVID-19 during pregnancy shows no affec

By: Dr. Liji Thomas-15 Aug, 2020

Has Delhi flattened COVID-19 curve?

By: CitizeMatters.in-15 Aug, 2020

Acupuncture may help with inflammation a

By: Myupchar-15 Aug, 2020

PM Modi to launch National Digital Healt

By: ET Bureau-15 Aug, 2020

WHO says food safe from coronavirus

By: AFP-15 Aug, 2020

Why flu vaccines do not protect people f

By: ScienceMag.org-15 Aug, 2020

Amid Covid-19 fear, Delhi hospital condu

By: ANI-14 Aug, 2020

A new way to monitor skin cancer: Scient

By: Myupchar-14 Aug, 2020

Covid-19: Human trials of Oxford vaccine

By: FE Online-14 Aug, 2020

Coronavirus India Live: Recovery rate in

By: FE Online-14 Aug, 2020

Zydus Cadila launches Indias cheapest re

By: FE Bureau-14 Aug, 2020

NHA governing board gives nod to integra

By: PTI-14 Aug, 2020

ePharmacies to tap approx 70 million Ind

By: EH News Bureau-14 Aug, 2020

Novavax Reports Encouraging Vaccine Resu

By: Carolyn Crist-05 Aug, 2020

"Patients From Outside": Delhi Health Mi

By: DelhiPress Trust of India-09 Aug, 2020

Billion Covid Vaccine Doses Could Be Ava

By: WorldReuters-06 Aug, 2020

New drug RLF-100 shows dramatic recovery

By: PTI-06 Aug, 2020

Biz of this immunity food not in the bes

By: Mayilvaganan-06 Aug, 2020

Read More

Partners & Associates